文献速递冠心病血脂与心血管预防

高强度间歇训练在心脏康复中的短期与长期可行性、安全性和疗效:FITR心脏研究随机临床试验

Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation: The FITR Heart Study Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2020-01-01

这项单中心随机临床试验纳入96例经血管造影证实的冠心病患者,比较4周监督下高强度间歇训练(HIIT)与中等强度持续训练(MICT)对峰值摄氧量的影响。HIIT可行且安全,12个月随访依从性与MICT相似。

要点

  • 4周HIIT较MICT更显著改善冠心病患者峰值摄氧量(10% vs 4%)。
  • 12个月时两组峰值摄氧量改善相似,HIIT可行且安全。
  • HIIT可作为心脏康复中中等强度运动的辅助或替代方式。

核心结论

  • 4周HIIT项目较MICT改善冠心病心脏康复患者的峰值摄氧量。
  • 12个月时两组峰值摄氧量改善相似,HIIT可行且安全,依从性与MICT相似。
  • 研究结果支持将HIIT作为中等强度运动的辅助或替代方式纳入心脏康复项目。

研究设计与样本

  • 单中心随机临床试验, participants接受4周监督下训练,随后家庭训练并随访12个月。
  • 共96例经血管造影证实的冠心病患者(18-80岁)入组,93例经心肺运动试验医学许可后随机分组。
  • HIIT组46例,MICT组47例;78例(84%)为男性,平均(SD)年龄65(8)岁。
  • 数据收集于2016年5月至2018年12月,分析于2018年12月至2019年8月。

主要发现

  • 两组可行性评分均高,因严重不良事件退出率低(HIIT组3例,MICT组1例)。
  • HIIT组发生1例运动后事件(低血压)。

临床怎么用

  • 4周HIIT项目可考虑用于冠心病心脏康复以改善峰值摄氧量。
  • HIIT可作为中等强度运动的辅助或替代方式纳入心脏康复项目。
  • 需注意家庭训练阶段依从性较低,应加强监督与随访。

局限性

  • 单中心研究,样本量有限,可能影响结果外推性。
  • 12个月时完成峰值摄氧量测试的参与者较少(HIIT组32例,MICT组37例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: High-intensity interval training (HIIT) is recognized as a potent stimulus for improving cardiorespiratory fitness (volume of oxygen consumption [VO2] peak) in patients with coronary artery disease (CAD). However, the feasibility, safety, and long-term effects of HIIT in this population are unclear. OBJECTIVE: To compare HIIT with moderate-intensity continuous training (MICT) for feasibility, safety, adherence, and efficacy of improving VO2 peak in patients with CAD. DESIGN, SETTING, AND PARTICIPANTS: In this single-center randomized clinical trial, participants underwent 4 weeks of supervised training in a private hospital cardiac rehabilitation program, with subsequent home-based training and follow-up over 12 months. A total of 96 participants with angiographically proven CAD aged 18 to 80 years were enrolled, and 93 participants were medically cleared for participation following a cardiopulmonary exercise test. Data were collected from May 2016 to December 2018, and data were analyzed from December 2018 to August 2019. INTERVENTIONS: A 4 × 4-minute HIIT program or a 40-minute MICT program (usual care). Patients completed 3 sessions per week (2 supervised and 1 home-based session) for 4 weeks and 3 home-based sessions per week thereafter for 48 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was change in VO2 peak during the cardiopulmonary exercise test from baseline to 4 weeks. Further testing occurred at 3, 6, and 12 months. Secondary outcomes were feasibility, safety, adherence, cardiovascular risk factors, and quality of life. RESULTS: Of 93 randomized participants, 78 (84%) were male, the mean (SD) age was 65 (8) years, and 46 were randomized to HIIT and 47 to MICT. A total of 86 participants completed testing at 4 weeks for the primary outcome, including 43 in the HIIT group and 43 in the MICT group; 69 completed testing at 12 months for VO2 peak, including 32 in the HIIT group and 37 in the MICT group. After 4 weeks, HIIT improved VO2 peak by 10% compared with 4% in the MICT group (mean [SD] oxygen uptake: HIIT, 2.9 [3.4] mL/kg/min; MICT, 1.2 [3.4] mL/kg/min; P = .02). After 12 months, there were similar improvements from baseline between groups, with a 10% improvement in the HIIT group and a 7% improvement in the MICT group (mean [SD] oxygen uptake: HIIT, 2.9 [4.5] mL/kg/min; MICT, 1.8 [4.3] mL/kg/min; P = .30). Both groups had high feasibility scores and low rates of withdrawal due to serious adverse events (3 participants in the HIIT group and 1 participant in the MICT group). One event occurred following exercise (hypotension) in the HIIT group. Over 12 months, both home-based HIIT and MICT had low rates of adherence (HIIT, 18 of 34 [53%]; MICT, 15 of 37 [41%]; P = .35) compared with the supervised stage (HIIT, 39 of 44 [91%]; MICT, 39 of 43 [91%]; P > .99). CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, a 4-week HIIT program improved VO2 peak compared with MICT in patients with CAD attending cardiac rehabilitation. However, improvements in VO2 peak at 12 months were similar for both groups. HIIT was feasible and safe, with similar adherence to MICT over 12-month follow-up. These findings support inclusion of HIIT in cardiac rehabilitation programs as an adjunct or alternative modality to moderate-intensity exercise. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry Identifier: ACTRN12615001292561.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Taylor JL, Holland DJ, Keating SE, et al. Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation: The FITR Heart Study Randomized Clinical Trial. JAMA Cardiol. 2020. PMID: 32876655. doi:10.1001/jamacardio.2020.3511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。